UniProt ID | Protein Name | Gene Symbol ▲ | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A851TH03 | Angiotensin-converting enzyme (Fragment) |
|
3 | 0 |
|
A0A851SKT6 | Angiotensin-converting enzyme (Fragment) |
|
1 | 0 |
|
A0A851TKZ6 | ATS1 metalloproteinase (Fragment) |
|
2 | 0 |
|
A0A851SVC4 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A851T4Y7 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A851TBZ4 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A851ST18 | BACE2 secretase (Fragment) |
|
2 | 0 |
|
A0A851T0X9 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A851TBN8 | Voltage-dependent T-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A851TBY7 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A851T761 | Cathepsin D (Fragment) |
|
2 | 0 |
|
A0A851T0N0 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
A0A851T9F1 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
A0A851TBZ1 | N-acetylgalactosamine-6-sulfatase (Fragment) |
|
2 | 0 |
|
A0A851T5H3 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A851TKE7 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A851T1B3 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A851TAH1 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A851TPD3 | ATP receptor (Fragment) |
|
1 | 0 |
|
A0A851T825 | AMD monooxygenase (Fragment) |
|
1 | 0 |
|
A0A851T7A2 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A851T2S7 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A851TL57 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A851SYX6 | RET kinase (Fragment) |
|
1 | 0 |
|
A0A851TDQ9 | Rhodopsin (Fragment) |
|
2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024